Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome.
European journal of case reports in internal medicine·2019
Same author
[Knowledge, expectancies and preferences in regard to the patient self-determination act among primary care patients].
Medicina clinica·2014
Same author
Polypharmacy in patients hospitalised for acute exacerbation of COPD.
The European respiratory journal·2014
[Chronic obstructive pulmonary disease in the elderly].
Pedro Almagro Mena1, Montserrat Llordés Llordés
1Unidad de Geriatría de Agudos, Servicio de Medicina Interna, Hospital Universitario Mútua de Terrassa, Terrasa, Barcelona, España. 19908pam@comb.cat
Revista Espanola De Geriatria Y Gerontologia
|December 17, 2011
Summary
Chronic obstructive pulmonary disease (COPD) affects the elderly, increasing with age. This review covers COPD physiology, diagnosis, and treatment in older adults, emphasizing geriatric syndrome prevention.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Area of Science:
- Pulmonology
- Geriatrics
- Internal Medicine
Context:
- Chronic obstructive pulmonary disease (COPD) is a highly prevalent respiratory illness, disproportionately affecting the elderly population and contributing to significant morbidity and mortality.
- COPD is characterized as an inflammatory condition with irreversible pulmonary obstruction, often accompanied by substantial comorbidity in older individuals.
- Managing COPD in the elderly requires personalized treatment strategies due to complex factors like multiple comorbidities, polypharmacy, and varied inhalation device usage.
Purpose:
- To provide an updated review of the physiology, diagnosis, and treatment of COPD specifically in the elderly population.
- To highlight the unique challenges and considerations for managing COPD in older adults.
- To discuss the prevention of geriatric syndromes associated with COPD.
Summary:
- COPD is a prevalent, inflammatory disease causing irreversible airflow limitation, with increased prevalence and mortality in the elderly.
- Treatment adaptation is crucial in elderly patients due to comorbidities, polypharmacy, and diverse inhalation techniques.
- Exacerbations, inactivity, systemic inflammation, and dyspnea contribute to functional decline in elderly COPD patients.
Impact:
- This review offers valuable insights for clinicians managing elderly COPD patients, aiming to improve treatment efficacy and patient outcomes.
- Understanding the interplay between COPD and geriatric syndromes is essential for comprehensive patient care.
- The findings support the need for tailored therapeutic approaches to mitigate the impact of COPD on physical function and quality of life in older adults.